IL6 and type 2 diabetes mellitus: Increased levels of IL-6, IL-1RA, sICAM-1 and E-selection in the “high” CRP group are reminiscent of subclinical systemic inflammation seen in obesity, metabolic syndrome or type 2 diabetes [31], [32], [33], [34].